Impella 5.5 and venovenous extracorporeal membrane oxygenation as a bridge to ventricular assist device in cardiopulmonary failure

(0 User reviews)   243   108
By Research Archive Posted on Jan 6, 2023
In Category - Research
Austin Kluis, David Rawitscher, Aasim M. Afzal, J. Michael DiMaio, Timothy J. George Baylor University Medical Center Proceedings (Taylor & Francis Online) 2023
English United States of America
Abstract
Venoarterial extracorporeal membrane oxygenation (ECMO) in the setting of combined cardiopulmonary failure provides full support of both cardiac and respiratory systems. However, it is difficult to isolate and evaluate pulmonary recovery independent of cardiac function on venoarterial ECMO. In this case report, we demonstrate the advantage of supporting a patient in cardiopulmonary failure with venovenous ECMO and the Impella 5.5 as a method to isolate organ dysfunction, wean off ECMO as respiratory function improves, and bridge to a left ventricular assist device with Impella 5.5 monotherapy.
Cardiopulmonary failure, extracorporeal membrane oxygenation, Impella, venovenous

Venoarterial extracorporeal membrane oxygenation (ECMO) in the setting of combined cardiopulmonary failure provides full support of both cardiac and respiratory systems. However, it is difficult to isolate and evaluate pulmonary recovery independent of cardiac function on venoarterial ECMO. In this case report, we demonstrate the advantage of supporting a patient in cardiopulmonary failure with venovenous ECMO and the Impella 5.5 as a method to isolate organ dysfunction, wean off ECMO as respiratory function improves, and bridge to a left ventricular assist device with Impella 5.5 monotherapy.

There are no reviews for this PDF.

0
0 out of 5 (0 User reviews )

Add a Review

Your Rating *
There are no comments for this PDF.
You must log in to post a comment.
Log in

Related PDF